Menu
Recruiting NCT07303114

Missed Opportunities for HIV Screening in General Practice

Observational HIV Infections

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: HIV Infections. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Missed Opportunities for HIV Screening in General Practice - A Retrospective Study

Overview

The number of new HIV diagnoses in France in 2022 is estimated to be between 4,200 and 5,700. Of these diagnoses, 43% of infections were detected at a late stage. The objective of this study is to identify missed opportunities for HIV testing in general practice and to understand the barriers to testing.

Primary outcome measures

  • Presence or absence of clinical signs suggestive of HIV infection [Time frame: 1 year preceding HIV diagnosis]

Eligibility criteria

Inclusion criteria

  • Adult subject (≥18 years)
  • diagnosed with HIV infection between January 1, 2021, and July 30, 2024

Exclusion criteria

-Subject who arrived in France in the year preceding or during the period between January 1, 2024, and July 30, 2024.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

France · 1 center
  • Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France — Strasbourg

Identifiers

NCT: NCT07303114 · 9478

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗